PNT 12.5 (+0%)
US7305411099BiotechnologyBiotechnology

POINT Biopharma Global (PNT) Stock Highlights

12.5 | +0%
2024-11-21 03:29:20
POINT Biopharma Global Inc is a clinical-stage global pharmaceutical company focused on the development and commercialization of radioligand therapies for the treatment of cancer. Its product pipeline includes PNT2002; PNT2004; PNT2003; PNT2001 and others.

Statistics

Range Today
12.5 12.5
Volume Today 0
Range 1 Year
6.57 14.35
Volume 1 Year 357.24M
Range 3 Year
4.25 18.08
Volume 3 Year 537.87M
Range 10 Year
4.25 21.44
Volume 10 Year 540.29M

Highlights

Market Capitalization 1.33B (small)
Floating Shares 87.47M
Current Price 12.5
Price To Earnings 11.36
Price To Revenue 4.12
Price To Book 3.12
Earnings Per Share 1.1
Payout Ratio 0%

Performance

Latest 0%
1 Month -10.07%
3 Months +84.09%
6 Months +42.21%
1 Year +84.91%
3 Years -12.77%
5 Years +1.05%
10 Years +1.05%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.